Perinatal Outcome After Premature Rupture of Membranes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01538030|
Recruitment Status : Completed
First Posted : February 23, 2012
Last Update Posted : August 15, 2012
|Condition or disease|
|Fetal Membranes Premature Rupture|
|Study Type :||Observational|
|Actual Enrollment :||80 participants|
|Official Title:||Perinatal Outcomes According to Amniotic Fluid Indez After Premature Rupture of Membranes. A Prospective Cohort Study.|
|Study Start Date :||May 2012|
|Actual Primary Completion Date :||August 2012|
|Actual Study Completion Date :||August 2012|
Amniotic Fluid Volume > 5
Pregnant patients with gestations between 24-34 weeks with premature rupture of membranes that, when the decision was made to interrupt the pregnancy, had amniotic fluid volume index above 5.1
Amniotic Fluid Volume < 5
Pregnant patients with gestations between 24-34 weeks with premature rupture of membranes that, when the decision was made to interrupt the pregnancy, had amniotic fluid volume index of 5 or less.
- Cesarean section rate [ Time Frame: 5 months ]Number of cases in each cohort that were interrupted by cesarean section due to fetal distress (evidence of cord dystocia).
- Perinatal mortality [ Time Frame: 5 months ]Number of perinatal deaths (ante, peri and postpartum until 28 days postpartum)in each cohort.
- Neonatal sepsis [ Time Frame: 5 months ]Number of cases of neonates diagnosed with sepsis in each cohort.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01538030
|Saint Thomas H|